日本人アルツハイマー病患者を対象としたアデュカヌマブ（BIIB037）の単回および複数回投与漸増試験

基本情報

NCT ID

NCT02434718

ステータス

完了

試験のフェーズ

第1相

試験タイプ

介入

目標被験者数

21

治験依頼者名

Biogen

概要

The primary objective of the study is to evaluate the safety and tolerability of single and multiple intravenous (IV) infusions of Aducanumab in Japanese participants with mild to moderate Alzheimer's Disease (AD). The secondary objectives of this study are as follows: To evaluate the serum pharmacokinetics (PK) of Aducanumab after single and multiple intravenous (IV) infusions of Aducanumab; To evaluate the effect of single and multiple IV infusions of Aducanumab on immunogenicity.

対象疾患

介入

依頼者（Sponsor）